Akero Therapeutics, Inc. Quarterly Marketable Securities, Current in USD from Q4 2018 to Q2 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of investment in marketable security, classified as current.
Summary
Akero Therapeutics, Inc. quarterly Marketable Securities, Current history and growth rate from Q4 2018 to Q2 2024.
  • Akero Therapeutics, Inc. Marketable Securities, Current for the quarter ending June 30, 2024 was $450M, a 130% increase year-over-year.
Marketable Securities, Current, Quarterly (USD)
Marketable Securities, Current, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q2 2024 $450M +$255M +130% Jun 30, 2024 10-Q 2024-08-09
Q1 2024 $280M +$194M +228% Mar 31, 2024 10-Q 2024-05-10
Q4 2023 $316M +$214M +211% Dec 31, 2023 10-Q 2024-08-09
Q3 2023 $285M +$285M Sep 30, 2023 10-Q 2023-11-13
Q2 2023 $195M +$192M +6414% Jun 30, 2023 10-Q 2023-08-11
Q1 2023 $85.3M +$70.5M +473% Mar 31, 2023 10-Q 2023-05-15
Q4 2022 $102M +$63.9M +169% Dec 31, 2022 10-K 2024-02-29
Q3 2022 $0 -$50.1M -100% Sep 30, 2022 10-Q 2022-11-04
Q2 2022 $3M -$69.5M -95.9% Jun 30, 2022 10-Q 2022-08-05
Q1 2022 $14.9M -$47.1M -76% Mar 31, 2022 10-Q 2022-05-06
Q4 2021 $37.8M -$43.4M -53.4% Dec 31, 2021 10-K 2023-03-17
Q3 2021 $50.1M -$49M -49.4% Sep 30, 2021 10-Q 2021-11-12
Q2 2021 $72.5M +$32.9M +83.1% Jun 30, 2021 10-Q 2021-08-13
Q1 2021 $62M -$16M -20.5% Mar 31, 2021 10-Q 2021-05-13
Q4 2020 $81.1M +$9.53M +13.3% Dec 31, 2020 10-K 2022-02-25
Q3 2020 $99.2M Sep 30, 2020 10-Q 2020-11-12
Q2 2020 $39.6M Jun 30, 2020 10-Q 2020-08-12
Q1 2020 $78M Mar 31, 2020 10-Q 2020-05-13
Q4 2019 $71.6M +$71.6M Dec 31, 2019 10-K 2021-03-16
Q4 2018 $0 Dec 31, 2018 10-K 2020-03-16
* An asterisk sign (*) next to the value indicates that the value is likely invalid.